Heimbach JC - Search Results

1

Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.

Fitzgerald PM, McKeever BM, VanMiddlesworth JF, Springer JP, Heimbach JC, Leu CT, Herber WK, Dixon RA, Darke PL. Fitzgerald PM, et al. Among authors: heimbach jc. J Biol Chem. 1990 Aug 25;265(24):14209-19. J Biol Chem. 1990. PMID: 2201682 Free article.

2

Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1.

McKeever BM, Navia MA, Fitzgerald PM, Springer JP, Leu CT, Heimbach JC, Herbert WK, Sigal IS, Darke PL. McKeever BM, et al. Among authors: heimbach jc. J Biol Chem. 1989 Feb 5;264(4):1919-21. J Biol Chem. 1989. PMID: 2644246 Free article.

3

Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.

Darke PL, Leu CT, Davis LJ, Heimbach JC, Diehl RE, Hill WS, Dixon RA, Sigal IS. Darke PL, et al. Among authors: heimbach jc. J Biol Chem. 1989 Feb 5;264(4):2307-12. J Biol Chem. 1989. PMID: 2644259 Free article.

4

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Navia MA, Fitzgerald PM, McKeever BM, Leu CT, Heimbach JC, Herber WK, Sigal IS, Darke PL, Springer JP. Navia MA, et al. Among authors: heimbach jc. Nature. 1989 Feb 16;337(6208):615-20. doi: 10.1038/337615a0. Nature. 1989. PMID: 2645523

5

Affinity purification of the HIV-1 protease.

Heimbach JC, Garsky VM, Michelson SR, Dixon RA, Sigal IS, Darke PL. Heimbach JC, et al. Biochem Biophys Res Commun. 1989 Nov 15;164(3):955-60. doi: 10.1016/0006-291x(89)91762-2. Biochem Biophys Res Commun. 1989. PMID: 2686642

6

Active human immunodeficiency virus protease is required for viral infectivity.

Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RA, Scolnick EM, Sigal IS. Kohl NE, et al. Among authors: heimbach jc. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90. doi: 10.1073/pnas.85.13.4686. Proc Natl Acad Sci U S A. 1988. PMID: 3290901 Free PMC article.

7

A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.

Tucker TJ, Lumma WC Jr, Payne LS, Wai JM, de Solms SJ, Giuliani EA, Darke PL, Heimbach JC, Zugay JA, Schleif WA, et al. Tucker TJ, et al. Among authors: heimbach jc. J Med Chem. 1992 Jul 10;35(14):2525-33. doi: 10.1021/jm00092a002. J Med Chem. 1992. PMID: 1635054

8

Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.

Darke PL, Kohl NE, Hanobik MG, Leu CT, Vacca JP, Guare JP, Heimbach JC, Dixon RA. Darke PL, et al. Among authors: heimbach jc. Adv Exp Med Biol. 1991;306:483-7. doi: 10.1007/978-1-4684-6012-4_61. Adv Exp Med Biol. 1991. PMID: 1812746 No abstract available.

9

Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 protease.

Herber WK, Bailey FJ, Carty CE, Heimbach JC, Maigetter RZ. Herber WK, et al. Among authors: heimbach jc. Appl Microbiol Biotechnol. 1991 Nov;36(2):149-52. doi: 10.1007/BF00164410. Appl Microbiol Biotechnol. 1991. PMID: 1368104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters